Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.350
-0.095 (-2.76%)
At close: Oct 23, 2026, 4:00 PM EDT
3.360
+0.010 (0.30%)
After-hours: Oct 23, 2026, 7:51 PM EDT
Cronos Group Revenue
Cronos Group had revenue of $53.01M in the quarter ending June 30, 2026, with 58.44% growth. This brings the company's total for the last twelve months to $179.09M, up 37.46% year-over-year. In the year 2025, Cronos Group had annual revenue of $146.59M with 24.63% growth.
Revenue (ttm)
$179.09M
Revenue Growth
+37.46%
P/S Ratio
6.90
Revenue / Employee
$293,585
Employees
610
Market Cap
1.24B
Revenue by Geography
- Canada 90.33M 61.6%
- Israel 41.80M 28.5%
- Other Countries 14.46M 9.9%
Fiscal year ended Dec 31, 2025 See the full Cronos Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.59M | 28.97M | 24.63% |
| Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
| Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
| Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
| Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
| Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
| Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
| Dec 31, 2018 | 12.12M | 8.97M | 285.16% |
| Dec 31, 2017 | 3.15M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | -572.29K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Phibro Animal Health | 1.52B |
| Trulieve Cannabis | 1.14B |
| ANI Pharmaceuticals | 978.38M |
| BioCryst Pharmaceuticals | 940.61M |
| Collegium Pharmaceutical | 808.21M |
| Pacira BioSciences | 746.16M |
| Amphastar Pharmaceuticals | 730.02M |
| Alvotech | 494.61M |
CRON News
- 10 days ago - Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company - GlobeNewsWire
- 12 days ago - Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season - GlobeNewsWire
- 17 days ago - Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026 - GlobeNewsWire
- 27 days ago - Cronos Group price target raised to C$7 from C$6 at TD Securities - TheFly
- 4 weeks ago - Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions - MarketBeat
- 4 weeks ago - Cronos Group Transcript: Investor Day 2026 - Transcripts
- 4 weeks ago - Cronos Group Slides: FY 2026 - Filings
- 4 weeks ago - Cronos Hosts 2026 Investor Day - GlobeNewsWire